Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × dactolisib × Clear all

Sponsor

Conditions

Neuroectodermal Tumors, Primitive 2 Neuroendocrine Tumors 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 20 atezolizumab 11 Gemcitabine 11 Nivolumab 8 Cisplatin 8 Docetaxel 7 Carboplatin 7 Mitomycin 5 avelumab 4 Ipilimumab 4 pemigatinib 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 lenvatinib 2 epacadostat 2 enfortumab vedotin 2 cabozantinib 2 Standard of Care 2 Rogaratinib 2 Ramucirumab 2 Platinum 2 Pemetrexed 2 Everolimus 2 Biopsy 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 valrubicin 1 trilaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡